This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: American Diagnostica, Inc.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: The Innovations of Safi Ranzurmal
Introduction
Safi Ranzurmal is an accomplished inventor based in Milford, CT (US). He has made significant contributions to the field of diagnostics, particularly in the measurement of ADAMTS13 activity. His work has implications for the treatment of thrombotic thrombocytopenic purpura (TTP), a serious blood disorder.
Latest Patents
Safi holds a patent for "Methods for measuring ADAMTS13 activity and protein on platelets and in plasma." This patent provides assays to detect ADAMTS13 activity using peptide substrates. These assays are valuable for diagnostic applications and evaluating treatment options for TTP. His innovative approach also includes the discovery of a novel form of ADAMTS13 found on platelets.
Career Highlights
Safi Ranzurmal is currently employed at American Diagnostica, Inc., where he continues to advance his research and development efforts. His work has been instrumental in enhancing diagnostic methodologies in the medical field.
Collaborations
Safi collaborates with Robert S Greenfield, contributing to the innovative environment at American Diagnostica, Inc. Their partnership fosters the development of cutting-edge diagnostic tools.
Conclusion
Safi Ranzurmal's contributions to the field of diagnostics through his patent and work at American Diagnostica, Inc. highlight his role as a significant inventor. His innovations are paving the way for improved diagnostic applications in medicine.